Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs SANOFI INDIA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NATCO PHARMA SANOFI INDIA NATCO PHARMA/
SANOFI INDIA
 
P/E (TTM) x 13.3 31.0 43.0% View Chart
P/BV x 3.5 15.4 22.7% View Chart
Dividend Yield % 0.6 7.0 8.2%  

Financials

 NATCO PHARMA   SANOFI INDIA
EQUITY SHARE DATA
    NATCO PHARMA
Mar-23
SANOFI INDIA
Dec-22
NATCO PHARMA/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs8477,939 10.7%   
Low Rs5025,454 9.2%   
Sales per share (Unadj.) Rs148.41,202.8 12.3%  
Earnings per share (Unadj.) Rs39.2269.5 14.5%  
Cash flow per share (Unadj.) Rs48.2287.7 16.7%  
Dividends per share (Unadj.) Rs5.50570.00 1.0%  
Avg Dividend yield %0.88.5 9.6%  
Book value per share (Unadj.) Rs267.1527.0 50.7%  
Shares outstanding (eoy) m182.4723.03 792.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.55.6 81.6%   
Avg P/E ratio x17.224.9 69.2%  
P/CF ratio (eoy) x14.023.3 60.1%  
Price / Book Value ratio x2.512.7 19.9%  
Dividend payout %14.0211.5 6.6%   
Avg Mkt Cap Rs m123,049154,224 79.8%   
No. of employees `000NANA-   
Total wages/salary Rs m4,8674,059 119.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m27,07127,701 97.7%  
Other income Rs m1,285730 176.0%   
Total revenues Rs m28,35628,431 99.7%   
Gross profit Rs m9,1178,349 109.2%  
Depreciation Rs m1,638419 390.9%   
Interest Rs m14517 852.9%   
Profit before tax Rs m8,6198,643 99.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,4662,437 60.2%   
Profit after tax Rs m7,1536,206 115.3%  
Gross profit margin %33.730.1 111.7%  
Effective tax rate %17.028.2 60.3%   
Net profit margin %26.422.4 117.9%  
BALANCE SHEET DATA
Current assets Rs m30,00336,121 83.1%   
Current liabilities Rs m6,83127,425 24.9%   
Net working cap to sales %85.631.4 272.7%  
Current ratio x4.41.3 333.5%  
Inventory Days Days63117 54.4%  
Debtors Days Days11517 678.6%  
Net fixed assets Rs m26,57112,148 218.7%   
Share capital Rs m365230 158.7%   
"Free" reserves Rs m48,37311,906 406.3%   
Net worth Rs m48,73812,136 401.6%   
Long term debt Rs m00-   
Total assets Rs m56,57448,279 117.2%  
Interest coverage x60.4509.4 11.9%   
Debt to equity ratio x00-  
Sales to assets ratio x0.50.6 83.4%   
Return on assets %12.912.9 100.1%  
Return on equity %14.751.1 28.7%  
Return on capital %18.071.4 25.2%  
Exports to sales %014.1 0.0%   
Imports to sales %10.214.6 70.3%   
Exports (fob) Rs mNA3,904 0.0%   
Imports (cif) Rs m2,7724,037 68.7%   
Fx inflow Rs m17,2563,904 442.0%   
Fx outflow Rs m2,7724,037 68.7%   
Net fx Rs m14,484-133 -10,910.7%   
CASH FLOW
From Operations Rs m8,4913,987 213.0%  
From Investments Rs m-4,7716,509 -73.3%  
From Financial Activity Rs m-3,630-15,827 22.9%  
Net Cashflow Rs m208-5,331 -3.9%  

Share Holding

Indian Promoters % 49.7 0.0 -  
Foreign collaborators % 0.0 60.4 -  
Indian inst/Mut Fund % 25.0 28.8 86.6%  
FIIs % 13.7 6.3 217.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 50.3 39.6 127.0%  
Shareholders   207,571 62,870 330.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NATCO PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Natco Pharma vs Sanofi India

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Natco Pharma vs Sanofi India Share Price Performance

Period Natco Pharma Sanofi India S&P BSE HEALTHCARE
1-Day -2.11% 2.06% 1.18%
1-Month -3.19% -8.09% -0.75%
1-Year 72.80% 44.45% 61.82%
3-Year CAGR 4.96% 0.97% 18.16%
5-Year CAGR 10.96% 7.07% 19.79%

* Compound Annual Growth Rate

Here are more details on the Natco Pharma share price and the Sanofi India share price.

Moving on to shareholding structures...

The promoters of Natco Pharma hold a 49.7% stake in the company. In case of Sanofi India the stake stands at 60.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Natco Pharma and the shareholding pattern of Sanofi India.

Finally, a word on dividends...

In the most recent financial year, Natco Pharma paid a dividend of Rs 5.5 per share. This amounted to a Dividend Payout ratio of 14.0%.

Sanofi India paid Rs 570.0, and its dividend payout ratio stood at 211.5%.

You may visit here to review the dividend history of Natco Pharma, and the dividend history of Sanofi India.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.